$IPXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Impax Laboratories, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Impax Laboratories, LLC. Get notifications about new insider transactions in Impax Laboratories, LLC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 08 2018 | IPXL | Impax Laboratories ... | Vergis Janet S. | Director | Option Exercise | D | 38.42 | 8,100 | 311,202 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Vergis Janet S. | Director | Option Exercise | D | 30.33 | 10,575 | 320,740 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Vergis Janet S. | Director | Option Exercise | D | 16.40 | 10,575 | 173,430 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Vergis Janet S. | Director | Sell | D | 0.00 | 5,508 | 0 | 0 | 5.5 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | Vergis Janet S. | Director | Sell | D | 0.00 | 6,642 | 0 | 0 | 6.6 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 6.55 | 45,000 | 294,750 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 20.30 | 10,000 | 203,000 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 27.97 | 10,000 | 279,700 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 20.90 | 10,000 | 209,000 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 17.99 | 12,000 | 215,880 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 25.24 | 11,500 | 290,260 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 44.85 | 7,300 | 327,405 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 30.33 | 10,575 | 320,740 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Option Exercise | D | 16.40 | 10,575 | 173,430 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Sell | D | 0.00 | 5,408 | 0 | 0 | 5.4 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | TERRERI PETER R | Director | Sell | D | 0.00 | 43,129 | 0 | 0 | 43.1 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | PENDERGAST MARY K | Director | Option Exercise | D | 20.36 | 12,000 | 244,320 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | PENDERGAST MARY K | Director | Option Exercise | D | 25.24 | 11,500 | 290,260 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | PENDERGAST MARY K | Director | Option Exercise | D | 44.85 | 7,300 | 327,405 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | PENDERGAST MARY K | Director | Option Exercise | D | 30.33 | 10,575 | 320,740 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | PENDERGAST MARY K | Director | Option Exercise | D | 16.40 | 10,575 | 173,430 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | PENDERGAST MARY K | Director | Sell | D | 0.00 | 5,408 | 0 | 0 | 5.4 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | PENDERGAST MARY K | Director | Sell | D | 0.00 | 16,942 | 0 | 0 | 16.9 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Option Exercise | D | 20.30 | 12,000 | 243,600 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Option Exercise | D | 27.97 | 10,000 | 279,700 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Option Exercise | D | 20.90 | 10,000 | 209,000 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Option Exercise | D | 17.99 | 12,000 | 215,880 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Option Exercise | D | 25.24 | 11,500 | 290,260 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Option Exercise | D | 44.85 | 7,300 | 327,405 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Option Exercise | D | 30.33 | 10,575 | 320,740 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Option Exercise | D | 16.40 | 10,575 | 173,430 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Sell | D | 0.00 | 5,408 | 0 | 0 | 5.4 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Sell | D | 0.00 | 116,000 | 0 | 0 | 116 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Sell | D | 0.00 | 180,000 | 0 | 0 | 180 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Sell | D | 0.00 | 20,000 | 0 | 0 | 20 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | CHAO ALLEN | Director | Sell | D | 0.00 | 64,037 | 0 | 0 | 64 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BUCHI J KEVIN | Director | Option Exercise | D | 14.45 | 20,445 | 295,430 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BUCHI J KEVIN | Director | Option Exercise | D | 16.40 | 7,931 | 130,068 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BUCHI J KEVIN | Director | Sell | D | 0.00 | 3,281 | 0 | 0 | 3.3 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BUCHI J KEVIN | Director | Sell | D | 0.00 | 8,020 | 0 | 0 | 8 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 6.55 | 30,000 | 196,500 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 20.30 | 19,000 | 385,700 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 27.97 | 19,000 | 531,430 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 20.90 | 16,000 | 334,400 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 17.99 | 25,000 | 449,750 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 25.24 | 19,600 | 494,704 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 35.89 | 2,750 | 98,698 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 44.85 | 12,000 | 538,200 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 30.33 | 10,575 | 320,740 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Option Exercise | D | 16.40 | 10,575 | 173,430 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Sell | D | 0.00 | 4,742 | 0 | 0 | 4.7 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Sell | D | 0.00 | 600 | 0 | 0 | 600 to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BENET LESLIE Z | Director | Sell | D | 0.00 | 17,741 | 0 | 0 | 17.7 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 6.55 | 30,000 | 196,500 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 20.30 | 10,000 | 203,000 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 27.97 | 10,000 | 279,700 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 20.90 | 10,000 | 209,000 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 17.99 | 12,000 | 215,880 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 25.24 | 11,500 | 290,260 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 44.85 | 7,300 | 327,405 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 30.33 | 10,575 | 320,740 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Option Exercise | D | 16.40 | 10,575 | 173,430 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Sell | D | 0.00 | 5,408 | 0 | 0 | 5.4 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Sell | D | 0.00 | 6,057 | 0 | 0 | 6.1 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BURR ROBERT L | Director | Sell | D | 0.00 | 55,067 | 0 | 0 | 55.1 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 21.24 | 100,000 | 2,124,000 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 20.90 | 21,667 | 452,840 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 17.99 | 52,000 | 935,480 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 25.24 | 55,000 | 1,388,200 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 40.70 | 47,500 | 1,933,250 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 33.27 | 52,801 | 1,756,689 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | D | 9.35 | 56,232 | 525,769 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Sell | D | 0.00 | 18,135 | 0 | 0 | 18.1 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Sell | D | 0.00 | 50,116 | 0 | 0 | 50.1 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 6.55 | 16,250 | 106,438 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 20.30 | 32,500 | 659,750 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 27.97 | 32,500 | 909,025 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 20.90 | 32,500 | 679,250 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 17.99 | 52,000 | 935,480 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 25.24 | 55,000 | 1,388,200 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 40.70 | 47,500 | 1,933,250 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 33.27 | 52,801 | 1,756,689 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | D | 9.35 | 56,232 | 525,769 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Sell | D | 0.00 | 19,728 | 0 | 0 | 19.7 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | NESTOR MICHAEL | President, Impax Sp ... | Sell | D | 0.00 | 56,796 | 0 | 0 | 56.8 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Option Exercise | D | 9.35 | 56,232 | 525,769 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Option Exercise | D | 24.42 | 50,500 | 1,233,210 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Sell | D | 0.00 | 41,756 | 0 | 0 | 41.8 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Sell | D | 0.00 | 14,145 | 0 | 0 | 14.1 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 17.99 | 52,000 | 935,480 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 25.24 | 55,000 | 1,388,200 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 40.70 | 47,500 | 1,933,250 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 33.27 | 63,095 | 2,099,171 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | D | 9.35 | 56,232 | 525,769 | 0 | |
May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Sell | D | 0.00 | 20,566 | 0 | 0 | 20.6 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | Reasons Bryan M. | Chief Financial Off ... | Sell | D | 0.00 | 53,423 | 0 | 0 | 53.4 K to 0 (-100.00 %) |
May 08 2018 | IPXL | Impax Laboratories ... | BISARO PAUL | President and CEO | Option Exercise | D | 12.70 | 850,000 | 10,795,000 | 0 | |
Mar 05 2018 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 19.50 | 2,436 | 47,502 | 79,582 | 82 K to 79.6 K (-2.97 %) |
Mar 05 2018 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Payment of Exercise | F | 19.50 | 2,041 | 39,800 | 78,549 | 80.6 K to 78.5 K (-2.53 %) |
Mar 05 2018 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 19.50 | 3,273 | 63,824 | 89,246 | 92.5 K to 89.2 K (-3.54 %) |
Mar 05 2018 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 19.50 | 3,069 | 59,846 | 94,684 | 97.8 K to 94.7 K (-3.14 %) |
Feb 27 2018 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 20.95 | 4,215 | 88,304 | 82,018 | 86.2 K to 82 K (-4.89 %) |
Feb 27 2018 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Payment of Exercise | F | 20.95 | 5,547 | 116,210 | 101,396 | 106.9 K to 101.4 K (-5.19 %) |
Feb 27 2018 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 20.95 | 6,141 | 128,654 | 97,753 | 103.9 K to 97.8 K (-5.91 %) |
Feb 27 2018 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 20.95 | 5,937 | 124,380 | 92,519 | 98.5 K to 92.5 K (-6.03 %) |
Oct 26 2017 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 19.60 | 2,734 | 53,586 | 86,233 | 89 K to 86.2 K (-3.07 %) |
Aug 02 2017 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Payment of Exercise | F | 17.85 | 5,282 | 94,284 | 80,590 | 85.9 K to 80.6 K (-6.15 %) |
Jun 01 2017 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Sell | S | 15.00 | 1,130 | 16,950 | 106,943 | 108.1 K to 106.9 K (-1.05 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Sell | S | 16.48 | 857 | 14,119 | 108,073 | 108.9 K to 108.1 K (-0.79 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Option Exercise | A | 16.40 | 10,575 | 173,430 | 10,575 | |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Grant | A | 0.00 | 4,375 | 0 | 48,537 | 44.2 K to 48.5 K (+9.91 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | BUCHI J KEVIN | Director | Option Exercise | A | 16.40 | 7,931 | 130,068 | 7,931 | |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | BUCHI J KEVIN | Director | Grant | A | 0.00 | 3,281 | 0 | 11,301 | 8 K to 11.3 K (+40.91 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | A | 16.40 | 10,575 | 173,430 | 10,575 | |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Grant | A | 0.00 | 4,375 | 0 | 22,483 | 18.1 K to 22.5 K (+24.16 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | PENDERGAST MARY K | Director | Option Exercise | A | 16.40 | 10,575 | 173,430 | 10,575 | |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | PENDERGAST MARY K | Director | Grant | A | 0.00 | 4,375 | 0 | 22,350 | 18 K to 22.4 K (+24.34 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Option Exercise | A | 16.40 | 10,575 | 173,430 | 10,575 | |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Grant | A | 0.00 | 4,375 | 0 | 69,445 | 65.1 K to 69.4 K (+6.72 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | Bierly Rick | Director | Option Exercise | A | 16.40 | 10,575 | 173,430 | 10,575 | |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | Bierly Rick | Director | Grant | A | 0.00 | 4,375 | 0 | 9,270 | 4.9 K to 9.3 K (+89.38 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | Vergis Janet S. | Director | Option Exercise | A | 16.40 | 10,575 | 173,430 | 10,575 | |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | Vergis Janet S. | Director | Grant | A | 0.00 | 4,375 | 0 | 12,150 | 7.8 K to 12.2 K (+56.27 %) |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Option Exercise | A | 16.40 | 10,575 | 173,430 | 10,575 | |
May 17 2017 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Grant | A | 0.00 | 4,375 | 0 | 60,475 | 56.1 K to 60.5 K (+7.80 %) |
May 16 2017 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 17.65 | 502 | 8,860 | 88,967 | 89.5 K to 89 K (-0.56 %) |
May 16 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 16.80 | 3,488 | 58,598 | 98,456 | 101.9 K to 98.5 K (-3.42 %) |
May 16 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 17.65 | 3,235 | 57,098 | 101,944 | 105.2 K to 101.9 K (-3.08 %) |
May 16 2017 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Payment of Exercise | F | 16.80 | 3,236 | 54,365 | 108,930 | 112.2 K to 108.9 K (-2.89 %) |
May 16 2017 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 16.80 | 454 | 7,627 | 103,894 | 104.3 K to 103.9 K (-0.44 %) |
May 16 2017 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 17.65 | 705 | 12,443 | 104,348 | 105.1 K to 104.3 K (-0.67 %) |
May 15 2017 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Payment of Exercise | F | 17.65 | 3,002 | 52,985 | 112,166 | 115.2 K to 112.2 K (-2.61 %) |
May 15 2017 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Sell | S | 17.11 | 700 | 11,977 | 115,168 | 115.9 K to 115.2 K (-0.60 %) |
Mar 29 2017 | IPXL | IMPAX LABORATORIES ... | BISARO PAUL | President and CEO | Option Exercise | A | 12.70 | 850,000 | 10,795,000 | 850,000 | |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Option Exercise | A | 9.35 | 41,842 | 391,223 | 41,842 | |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Grant | A | 0.00 | 17,317 | 0 | 89,469 | 72.2 K to 89.5 K (+24.00 %) |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Option Exercise | A | 9.35 | 56,232 | 525,769 | 56,232 | |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Grant | A | 0.00 | 23,272 | 0 | 115,868 | 92.6 K to 115.9 K (+25.13 %) |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 9.35 | 56,232 | 525,769 | 56,232 | |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 23,272 | 0 | 105,179 | 81.9 K to 105.2 K (+28.41 %) |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | A | 9.35 | 56,232 | 525,769 | 56,232 | |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Grant | A | 0.00 | 23,272 | 0 | 105,053 | 81.8 K to 105.1 K (+28.46 %) |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Option Exercise | A | 9.35 | 56,232 | 525,769 | 56,232 | |
Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Grant | A | 0.00 | 23,272 | 0 | 85,872 | 62.6 K to 85.9 K (+37.18 %) |
Feb 27 2017 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 14.05 | 5,715 | 80,296 | 81,781 | 87.5 K to 81.8 K (-6.53 %) |
Feb 27 2017 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 14.05 | 6,014 | 84,497 | 81,907 | 87.9 K to 81.9 K (-6.84 %) |
Feb 27 2017 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Payment of Exercise | F | 14.05 | 5,594 | 78,596 | 92,596 | 98.2 K to 92.6 K (-5.70 %) |
Feb 27 2017 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 14.05 | 4,301 | 60,429 | 72,152 | 76.5 K to 72.2 K (-5.63 %) |
Nov 28 2016 | IPXL | IMPAX LABORATORIES ... | BUCHI J KEVIN | Director | Option Exercise | A | 14.45 | 20,445 | 295,430 | 20,445 | |
Nov 28 2016 | IPXL | IMPAX LABORATORIES ... | BUCHI J KEVIN | Director | Grant | A | 0.00 | 8,020 | 0 | 8,020 | 0 to 8 K |